UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022656
Receipt No. R000024658
Official scientific title of the study Evaluation of Sairei-To for postoperative pharyngeal pain and hoarseness
Date of disclosure of the study information 2016/06/10
Last modified on 2017/08/13 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of Sairei-To for postoperative pharyngeal pain and hoarseness
Title of the study (Brief title) Sairei-To for postoperative pharyngeal pain and hoarseness
Region
Japan

Condition
Condition Patient who undergo general anesthesia with tracheal intubation
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of postoperative pharyngeal pain and hoarseness
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postoperative hoarseness and pharyngeal pain
Key secondary outcomes Postoperative nausea and vomit
Perioperative anxiety

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Take 2 times of 2.5 g Sairei-To before sleep and the morning
Interventions/Control_2 Do not take Sairei-To
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >
Gender Female
Key inclusion criteria Patient who undergo general anesthesia with tracheal intubation
Key exclusion criteria Patient who take Kampo or analgesics
Target sample size 80

Research contact person
Name of lead principal investigator Toshiaki Minami
Organization Osaka Medical College
Division name Anesthesiology
Address Daigaku-machi 2-7
TEL 0726-84-6361
Email ane22@osaka-med.ac.jp

Public contact
Name of contact person Komasawa Nobuyasu
Organization Osaka Medical College
Division name Anesthesiology
Address 2-7 Daigaku-machi
TEL 0726-84-6361
Homepage URL
Email ane022@osaka-med.ac.jp

Sponsor
Institute Osaka Medical College
Institute
Department

Funding Source
Organization Daiichi Towakai Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 10 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 06 Month 08 Day
Anticipated trial start date
2016 Year 06 Month 12 Day
Last follow-up date
2017 Year 08 Month 12 Day
Date of closure to data entry
2017 Year 08 Month 14 Day
Date trial data considered complete
2017 Year 08 Month 15 Day
Date analysis concluded
2017 Year 08 Month 17 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results The perioperative stress or anxiety did not differe by preoperative Saireito administration.
Other related information There was no significant difference between the groups.

Management information
Registered date
2016 Year 06 Month 08 Day
Last modified on
2017 Year 08 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024658